| 000 | 01175 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513133104.0 | ||
| 264 | 0 | _c19980212 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0891-5520 | ||
| 024 | 7 |
_a10.1016/s0891-5520(05)70398-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEspinel-Ingroff, A | |
| 245 | 0 | 0 |
_aClinical relevance of antifungal resistance. _h[electronic resource] |
| 260 |
_bInfectious disease clinics of North America _cDec 1997 |
||
| 300 |
_a929-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAmphotericin B _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
| 650 | 0 | 4 |
_aCandidiasis _xdrug therapy |
| 650 | 0 | 4 |
_aCryptococcosis _xdrug therapy |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aFluconazole _xpharmacology |
| 650 | 0 | 4 |
_aFlucytosine _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aItraconazole _xpharmacology |
| 650 | 0 | 4 |
_aMycoses _xdrug therapy |
| 773 | 0 |
_tInfectious disease clinics of North America _gvol. 11 _gno. 4 _gp. 929-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0891-5520(05)70398-6 _zAvailable from publisher's website |
| 999 |
_c9391275 _d9391275 |
||